Citation Impact
Citing Papers
Accurate Reconstruction of the Temporal Order of Mutations in Neoplastic Progression
2011
Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis
2006
Computational Radiomics System to Decode the Radiographic Phenotype
2017 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Blockade of Epidermal Growth Factor- or Heregulin-Dependent ErbB2 Activation with the Anti-ErbB2 Monoclonal Antibody 2C4 Has Divergent Downstream Signaling and Growth Effects
2004
Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer
1994
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
2003
Comparative methodological analysis of erbB‐2/HER‐2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use
2000
EXPRESSION OF THE TYPE 1 TYROSINE KINASE GROWTH FACTOR RECEPTORS EGF RECEPTOR, c-erbB2 AND c-erbB3 IN BLADDER CANCER
1996
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Evaluating thyroid nodules: predicting and selecting malignant nodules for fine-needle aspiration (FNA) cytology
2013
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Prognostic Factors in Breast Cancer
2000
Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.
1998
EGFR Antagonists in Cancer Treatment
2008 Standout
Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations
2007
P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast
2002
The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours
1997
Comparison of 5‐tiered and 6‐tiered diagnostic systems for the reporting of thyroid cytopathology
2011
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules
2006
Follicular-Patterned Lesions of the Thyroid
2002
Thyroid cancer
2016 Standout
The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast
1999
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology
1995
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
2010
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008 Standout
Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium
2010
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17
1999
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Genetic instabilities in human cancers
1998 StandoutNature
The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules
2009
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications
2010
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Ductal Carcinoma in Situ of the Breast: a New Phenotype Classification System and its Relation to Prognosis
2002
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
2012 Standout
The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a Summation
2008
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
1997
Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer
1999
Pathological prognostic factors in breast cancer
1999 Standout
NSAIDs Modulate Clonal Evolution in Barrett's Esophagus
2013
Intra-tumour heterogeneity: a looking glass for cancer?
2012
A tense situation: forcing tumour progression
2009 Standout
Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept
2002
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Immunohistochemical Distinction of Follicular Thyroid Adenomas and Follicular Carcinomas
2008
Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18 000 FNAs reported at the same institution during 1998-2007
2010
Oesophageal carcinoma
2013 Standout
Ductal Carcinoma In Situ, Complexities and Challenges
2004
The microenvironment of the tumour–host interface
2001 StandoutNature
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast
2001 StandoutNobel
Male breast cancer
2006 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853
2000
Synchronous bilateral noninvasive ductal carcinoma of the male breast: A case report
2003
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Human AlkB Homologue 5 Is a Nuclear 2-Oxoglutarate Dependent Oxygenase and a Direct Target of Hypoxia-Inducible Factor 1α (HIF-1α)
2011 StandoutNobel
Changes in breast cancer therapy because of pathology second opinions
2002
Emerging Biological Principles of Metastasis
2017 Standout
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
1998
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Distinct Angiogenic patterns are associated with high-gradein situ ductal carcinomas of the breast
1997
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference
2008 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology
2011
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience
2001
Clonal evolution in cancer
2012 StandoutNature
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
2003 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?
2000
Role of repeat fine‐needle aspiration biopsy (FNAB) in the management of thyroid nodules
2003
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10–14 mm invasive breast cancers: a prospective study
2000
Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients
2003
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions
1995
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
1998
Tenascin—A Marker for the Malignant Potential of Preinvasive Breast Cancers
2000
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Clonality Assessment and Clonal Ordering of Individual Neoplastic Crypts Shows Polyclonality of Colorectal Adenomas
2010
Breast cancer metastasis: markers and models
2005 Standout
Screening Fundamentals
1997
Bile Acid and Inflammation Activate Gastric Cardia Stem Cells in a Mouse Model of Barrett-Like Metaplasia
2012
The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution
2009
Ductal carcinoma in situ of the breast
1997
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation
2013
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Type 1 growth factor receptors: an overview of recent developments
1995
Mechanisms of Estrogen Action
2001 Standout
Thy3 cytology: what to do next?
2011
Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
2015
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
DCIS grading schemes and clinical implications
1999
Guidelines for the management of thyroid cancer
2014 Standout
Multicenter Clinical Experience With the Afirma Gene Expression Classifier
2013
Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast
1996
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 Standout
Predictors of local recurrence after treatment of ductal carcinoma in situ
1999
Works of David Poller being referenced
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
1994
p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein
1993
Correlations between the mammographic features of ductal carcinoma In situ (DCIS) and C-erbB-2 oncogene expression
1994
Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.
1994
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus
2008
A prognostic index for ductal carcinoma in situ of the breast
1996
The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists’ Classification System
2011
Referrals for second opinion in surgical pathology: implications for management of cancer patients in the UK
2001
Production and characterization of a polyclonal antibody to the c‐erb B‐3 protein: Examination of c ‐erb B‐3 protein expression in adenocarcinomas
1992
Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
1994
Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast
1995
Galectin‐3 is not useful in thyroid FNA
2005
Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma
1991
Cathepsin D in primary breast carcinoma: Adverse prognosis is associated with expression of cathepsin D in stromal cells
1995
Thyroid FNAC cytology: can we do it better?
2007
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study
2012
Prognostic classification of breast ductal carcinoma-in-situ
1995
Fine-needle aspiration of the thyroid
2000
Rapid on‐site assessment of specimens by biomedical scientists improves the quality of head and neck fine needle aspiration cytology
2013
The Van Nuys Prognostic Index for Ductal Carcinoma In Situ
1996
CONFIRMATION OF THE REPRODUCIBILITY OF THYROID FNA USING THE 2009 UK ROYAL COLLEGE OF PATHOLOGISTS 'THY' REPORTING NOMENCLATURE
2010
A simplified economic approach to thyroid FNA cytology and surgical intervention in thyroid nodules
2013